JCR Pharmaceuticals Co., Ltd.
Simbolis: JCRRF
PNK
6.2
USDRinkos kaina šiandien
18.8882
P/E santykis
-0.0016
PEG koeficientas
773.77M
MRK kapitalizacija
- 0.00%
DIV pajamingumas
JCR Pharmaceuticals Co., Ltd. (JCRRF) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13278 | 30977 | 26260 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -214 | 244 | -225 | |||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 11137 | 15585 | 8183 | |||||||||||||||||||
balance-sheet.row.inventory | 0 | 18514 | 14636 | 13554 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 4873 | 990 | 548 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 47802 | 62188 | 48545 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 32681 | 26782 | 17172 | |||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3652 | 2960 | 3232 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 9081 | 1986 | 2797 | |||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1357 | 2433 | 1739 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 362 | 783 | 296 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 47133 | 34944 | 25236 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 2 | 2 | 3 | |||||||||||||||||||
balance-sheet.row.total-assets | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.account-payables | 0 | 1563 | 1324 | 2932 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 17300 | 15150 | 12850 | |||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 33 | 5915 | 2646 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5500 | 2950 | 5250 | |||||||||||||||||||
Deferred Revenue Non Current | 0 | -428 | -343 | -378 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 12975 | 13472 | 9687 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6763 | 3994 | 6203 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 73 | 44 | 42 | |||||||||||||||||||
balance-sheet.row.total-liab | 0 | 42525 | 46048 | 35231 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0 | 9061 | 9061 | 9061 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 34273 | 33241 | 20904 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1421 | 1184 | 1159 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7406 | 7395 | 7255 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52161 | 50881 | 38379 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 94937 | 97134 | 73784 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 251 | 205 | 174 | |||||||||||||||||||
balance-sheet.row.total-equity | 0 | 52412 | 51086 | 38553 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||
Total Investments | 0 | 8867 | 2230 | 2572 | |||||||||||||||||||
balance-sheet.row.total-debt | 0 | 22800 | 18100 | 18100 | |||||||||||||||||||
balance-sheet.row.net-debt | 0 | 9522 | -12633 | -8160 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -9221 | -3074 | -983 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 173 | 177 | 149 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2956 | -9030 | 323 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | 3269 | -7501 | -204 | |||||||||||||||||||
cash-flows.row.inventory | 0 | -3877 | -1082 | -4699 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 238 | -1608 | 2253 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2586 | 1161 | 2973 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -905 | -133 | 307 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -6717 | 8167 | -2747 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -906 | -300 | -391 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 300 | 584 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 922 | -84 | 6791 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -15002 | -3250 | -3290 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -3050 | -750 | -650 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 10 | 10 | 13 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -10 | -10 | -13 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2739 | -2169 | -1083 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 7737 | 740 | 10037 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 1948 | -2179 | 8304 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 1099 | 612 | -22 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -17455 | 4473 | 15332 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 13278 | 30733 | 26260 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 30733 | 26260 | 10928 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -5500 | 9289 | 10341 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -8560 | -11333 | -7527 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -14060 | -2044 | 2814 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 34343 | 51082 | 30085 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 8886 | 10461 | 7812 | |||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 25457 | 40621 | 22273 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 20480 | 20686 | 14003 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 29366 | 31147 | 21815 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 33 | 7 | 7 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 58 | 38 | 61 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 437 | -529 | 384 | |||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 44 | 45 | 42 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1997 | 1945 | 1892 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | 0 | 4975 | 19933 | 8269 | |||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 5412 | 19404 | 8653 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1625 | 4886 | 1764 | |||||||||||||||||||
income-statement-row.row.net-income | 0 | 3772 | 14507 | 6892 |
Dažnai užduodami klausimai
Kas yra JCR Pharmaceuticals Co., Ltd. (JCRRF) bendras turtas?
JCR Pharmaceuticals Co., Ltd. (JCRRF) bendras turtas yra 94937000000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.748.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 45.128.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.130.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.189.
Kas yra JCR Pharmaceuticals Co., Ltd. (JCRRF) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 3772000000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 22800000000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 20480000000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.